Renal function during hospitalization and outcome in Chinese patients with acute decompensated heart failure: A retrospective study and literature review

被引:1
作者
Lee, Hao-Wei [1 ]
Huang, Chin-Chou [1 ,2 ,3 ,4 ]
Yang, Chih-Yu [2 ,5 ,6 ]
Leu, Hsin-Bang [1 ,2 ,4 ,7 ]
Huang, Po-Hsun [1 ,4 ,6 ,8 ]
Wu, Tao-Cheng [1 ,2 ,4 ]
Lin, Shing-Jong [1 ,4 ,6 ,9 ]
Chen, Jaw-Wen [1 ,3 ,4 ,7 ]
机构
[1] Taipei Vet Gen Hosp, Dept Med, Div Cardiol, 201,Sect 2,Shih Pai Rd, Taipei, Taiwan
[2] Natl Yang Ming Chiao Tung Univ, Sch Med, Taipei, Taiwan
[3] Natl Yang Ming Chiao Tung Univ, Inst Pharmacol, Taipei, Taiwan
[4] Natl Yang Ming Chiao Tung Univ, Cardiovasc Res Ctr, Taipei, Taiwan
[5] Taipei Vet Gen Hosp, Dept Med, Div Nephrol, Taipei, Taiwan
[6] Natl Yang Ming Chiao Tung Univ, Inst Clin Med, Taipei, Taiwan
[7] Taipei Vet Gen Hosp, Healthcare & Serv Ctr, Taipei, Taiwan
[8] Taipei Vet Gen Hosp, Dept Crit Care Med, Taipei, Taiwan
[9] Taipei Med Univ, Taipei Heart Inst, Taipei, Taiwan
关键词
acute decompensated heart failure; cardiovascular event; hospitalization; renal function; worsening renal function; CHRONIC KIDNEY-DISEASE; LONG-TERM OUTCOMES; SERUM CREATININE; MEDICARE BENEFICIARIES; MORTALITY; ASSOCIATIONS; IMPACT; DYSFUNCTION; PREVALENCE; INSIGHTS;
D O I
10.1002/clc.23934
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background The heart and kidneys had demonstrated a bidirectional interaction that dysfunction of the heart or kidneys can induce dysfunction in the other organ. Hypothesis Renal function and its decline during hospitalization may have impact on cardiovascular outcomes in patients with acute decompensated heart failure (ADHF). Methods A total of 119 consecutive Chinese patients admitted for ADHF were prospectively enrolled. The course of renal function was presented with estimated glomerular filtration rate (eGFR), calculated by the four-variable equation proposed by the Modification of Diet in Renal Disease (MDRD) Study. Worsening renal function (WRF) was defined as eGFR decline between admission (eGFR(admission)) and predischarge (eGFR(predischarge)). Clinical outcomes were defined as 4P-major adverse cardiovascular events (4P-MACE), including the composition of cardiovascular death, nonfatal myocardial infarction, nonfatal stroke, and nonfatal HF hospitalization. Results During an average 2.6 +/- 3.2 years follow-up, 66 patients (55%) experienced 4P-MACE. Patients with impaired eGFR(predischarge) (<60 ml/min/1.73 m(2)) had more 4P-MACE than those with preserved eGFR(predischarge) (64.7% vs. 43.1%, p = .019). The Kaplan-Meier survival curves showed significantly higher incidence of 4P-MACE in patients with impaired eGFR(predischarge) than those with preserved eGFR(predischarge) (p = .002). Cox regression analysis revealed that impaired eGFR(predischarge) was significantly correlated with the development of 4P-MACE (hazard ratio, 2.003; 95% confidence interval, 1.072-3.744; p = .029). In contrast, outcomes would be similar with regard to eGFR on admission and eGFR decline during hospitalization. Conclusions Impaired renal function before discharge, but not impaired renal function on admission or WRF, is a significant risk factor for poor outcomes in patients with ADHF.
引用
收藏
页码:57 / 66
页数:10
相关论文
共 50 条
  • [31] Effect and Clinical Prediction of Worsening Renal Function in Acute Decompensated Heart Failure
    Breidthardt, Tobias
    Socrates, Thenral
    Noveanu, Markus
    Klima, Theresia
    Heinisch, Corinna
    Reichlin, Tobias
    Potocki, Mihael
    Nowak, Albina
    Tschung, Christopher
    Arenja, Nisha
    Bingisser, Roland
    Mueller, Christian
    AMERICAN JOURNAL OF CARDIOLOGY, 2011, 107 (05) : 730 - 735
  • [32] Renal function and acute heart failure outcome
    Llauger, Lluis
    Jacob, Javier
    Miro, Oscar
    MEDICINA CLINICA, 2018, 151 (07): : 281 - 290
  • [33] Prognostic importance of improving hepatorenal function during hospitalization in acute decompensated heart failure
    Mizobuchi, Saki
    Saito, Yuki
    Fujito, Hidesato
    Miyagawa, Masatsugu
    Kitano, Daisuke
    Toyama, Kazuto
    Fukamachi, Daisuke
    Okumura, Yasuo
    ESC HEART FAILURE, 2022, 9 (05): : 3113 - 3123
  • [34] Frequency, predictors and prognosis of worsening renal function in patients admitted with acute heart failure
    Kumar, Vinod
    Aijaz, Saba
    Sattar, Sadia
    Pathan, Asad
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2020, 70 (05) : 878 - 883
  • [35] Interaction Between Worsening Renal Function and Persistent Congestion in Acute Decompensated Heart Failure
    Wattad, Malak
    Darawsha, Wisam
    Solomonica, Amir
    Hijazi, Maher
    Kaplan, Marielle
    Makhoul, Badira F.
    Abassi, Zaid A.
    Azzam, Zaher S.
    Aronson, Doron
    AMERICAN JOURNAL OF CARDIOLOGY, 2015, 115 (07) : 932 - 937
  • [36] Potential aetiologies and prognostic implications of worsening renal function in acute decompensated heart failure
    Abo-Salem, Elsayed
    Sherif, Khalid
    Dunlap, Stephanie
    Prabhakar, Sharma
    ACTA CARDIOLOGICA, 2014, 69 (06) : 657 - 663
  • [37] Fluid loss, venous congestion, and worsening renal function in acute decompensated heart failure
    Aronson, Doron
    Abassi, Zaid
    Allon, Eyal
    Burger, Andrew J.
    EUROPEAN JOURNAL OF HEART FAILURE, 2013, 15 (06) : 637 - 643
  • [38] Impact of changes in blood pressure during the treatment of acute decompensated heart failure on renal and clinical outcomes
    Testani, Jeffrey M.
    Coca, Steven G.
    McCauley, Brian D.
    Shannon, Richard P.
    Kimmel, Stephen E.
    EUROPEAN JOURNAL OF HEART FAILURE, 2011, 13 (08) : 877 - 884
  • [39] Clinical characteristics and one-year mortality according to admission renal function in patients with a first acute heart failure hospitalization
    Formiga, Francesc
    Moreno-Gonzalez, Rafael
    Chivite, David
    Casado, Jesus
    Escrihuela-Vidal, Francesc
    Corbella, Xavier
    REVISTA PORTUGUESA DE CARDIOLOGIA, 2018, 37 (02) : 159 - 165
  • [40] Levosimendan Improves Renal Function in Acute Decompensated Heart Failure: Cause and Clinical ApplicationEditorial to: “Levosimendan Improves Renal Function in Patients with Acute Decompensated Heart Failure: Comparison with Dobutamine by Yilmaz et al.”
    K. Damman
    A. A. Voors
    Cardiovascular Drugs and Therapy, 2007, 21 (6) : 403 - 404